-

Mountainside Urges Maternal Mental Health Awareness Amid Panettiere Death and Clancy Trial

NEW YORK--(BUSINESS WIRE)--The death of actress Hayden Panettiere and the ongoing murder trial of Lindsay Clancy have placed maternal mental health at the center of national conversation, raising questions about how postpartum conditions are recognized and treated.

“A mother may love her child deeply while still feeling frightened, detached or unlike herself." —Jana Wu, Director of Clinical Integration at Mountainside

Share

Panettiere, who died at age 36, spoke publicly about postpartum depression and its overlap with alcohol use. Meanwhile, testimony in Clancy’s trial has focused on her mental health before the deaths of her three children. Her defense argues that she experienced postpartum psychosis and was not criminally responsible; prosecutors maintain that she acted deliberately. The trial remains ongoing.

“These are profoundly different circumstances, and we must be careful not to collapse them into one story,” said Jana Wu, LCSW, LADC, ICADC, Director of Clinical Integration at Mountainside Treatment Center. “Together, however, they are exposing how much fear, confusion and shame still surround maternal mental health—and how difficult it can be to recognize when distress has become a crisis.”

Postpartum depression can include persistent sadness, anxiety, numbness, withdrawal and difficulty experiencing joy. Postpartum psychosis is a rarer psychiatric emergency that can involve delusions, hallucinations, paranoia or severe confusion. Postpartum depression does not mean a mother will develop psychosis or harm herself or her child.

“One danger is reinforcing the idea that mothers experiencing postpartum depression should be feared,” Wu said. “Most are not dangerous. They are suffering, often silently, and need compassionate, evidence-based care.”

“A mother may love her child deeply while still feeling frightened, detached or unlike herself,” Wu said. “Those feelings do not mean she is broken or unloving. They mean she may need support.”

Wu urged the public not to speculate about Panettiere’s death or reach conclusions about Clancy’s mental state beyond evidence presented in court.

“The lesson should not be that maternal mental illness inevitably ends in tragedy,” Wu said. “It should be that honesty, early recognition and appropriate intervention can save lives.”

About Mountainside Treatment Center

Mountainside Treatment Center is a nationally recognized behavioral health organization specializing in the treatment of substance use disorders and co-occurring mental health conditions. Through evidence-based care, innovative programming, and community partnerships, Mountainside helps build meaningful lives in recovery.

Contacts

Media Contact:
Griffin Gonzales
Mountainside Treatment Center
griffin.gonzales@mountainside.com
(231) 794-9450

Mountainside Treatment Center


Release Versions

Contacts

Media Contact:
Griffin Gonzales
Mountainside Treatment Center
griffin.gonzales@mountainside.com
(231) 794-9450

Social Media Profiles
More News From Mountainside Treatment Center

Mountainside Warns About The Dangers of K-Holes And Why They're Scarier Than You Think

NEW YORK--(BUSINESS WIRE)--There has been a lot of talk lately about ketamine, but many people don’t understand the risks of a “K-hole,” the vernacular for the trance-like state it can produce. Ketamine is a dissociative anesthetic, used for decades in human and veterinary medicine to sedate patients and relieve pain. The Drug Enforcement Administration (DEA) notes that it distorts sight and sound and leaves users feeling disoriented and not in control. At higher recreational doses, the detachm...

Mountainside Warns of Ketamine Risks at American Colleges and Universities

NEW YORK--(BUSINESS WIRE)--As recent headlines ignite conversations about ketamine use across campuses, Mountainside Treatment Center is urging colleges and universities to ensure students have clear information about the dangers of ketamine and to make support available to the campus community. Ketamine was first synthesized in 1962 and approved by the U.S. FDA in 1970. It is primarily used as an anesthetic in medical settings but has gained attention for its off-label use in treating conditio...

Mountainside Issues Warning on Kratom and Cychlorphine Following Ole Miss Student Deaths

NEW YORK--(BUSINESS WIRE)--Following the deaths of two University of Mississippi students, Mountainside is urging families and college communities to seek reliable information about kratom and cychlorphine, an emerging synthetic opioid. Authorities reported finding retail-packaged kratom during two separate death investigations. They have not determined that kratom or any other substance contributed to either death, established that the deaths are connected, or reported finding cychlorphine in...
Back to Newsroom